ArticleFrontiers in immunology2024

Integrated multi-level omics profiling of disulfidptosis identifis SPAG4 as an innovative immunotherapeutic target in glioblastoma.

Shenbo Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.